Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,878 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.
Kurosawa S, Yamaguchi T, Uchida N, Miyawaki S, Usuki K, Watanabe M, Yamashita T, Kanamori H, Tomiyama J, Nawa Y, Yano S, Takeuchi J, Yakushiji K, Sano F, Uoshima N, Yano T, Nannya Y, Moriuchi Y, Miura I, Takaue Y, Fukuda T. Kurosawa S, et al. Among authors: yano s, yano t. Biol Blood Marrow Transplant. 2011 Mar;17(3):401-11. doi: 10.1016/j.bbmt.2010.07.013. Epub 2010 Jul 25. Biol Blood Marrow Transplant. 2011. PMID: 20667478 Free article.
Approaches to Quality Risk Management When Using Single-Use Systems in the Manufacture of Biologics.
Ishii-Watabe A, Hirose A, Katori N, Hashii N, Arai S, Awatsu H, Eiza A, Hara Y, Hattori H, Inoue T, Isono T, Iwakura M, Kajihara D, Kasahara N, Matsuda H, Murakami S, Nakagawa T, Okumura T, Omasa T, Takuma S, Terashima I, Tsukahara M, Tsutsui M, Yano T, Kawasaki N. Ishii-Watabe A, et al. Among authors: yano t. AAPS PharmSciTech. 2015 Oct;16(5):993-1001. doi: 10.1208/s12249-015-0368-z. Epub 2015 Aug 20. AAPS PharmSciTech. 2015. PMID: 26288941 Free PMC article.
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.
Ohira M, Imaoka Y, Sato K, Imaoka K, Bekki T, Yano T, Nakano R, Sakai H, Kuroda S, Tahara H, Ide K, Kobayashi T, Tanaka Y, Tanaka J, Ohdan H. Ohira M, et al. Among authors: yano t. PLoS One. 2025 Jan 16;20(1):e0313102. doi: 10.1371/journal.pone.0313102. eCollection 2025. PLoS One. 2025. PMID: 39820189 Clinical Trial.
2,878 results